Search company, investor...

Total Raised

$49.6M

Investors Count

4

Deal Terms

1

Funding, Valuation & Revenue

4 Fundings

Arivale has raised $49.6M over 4 rounds.

Arivale's latest funding round was a Dead for on April 25, 2019.

Arivale's valuation in July 2015 was $107.22M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/25/2019

Dead

Dead

$99M

0

FY undefined

1

6/13/2017

Unattributed

$99M

$99M

0

FY undefined

10

7/14/2015

Series B

$99M

$107.22M

0

FY undefined

10

3/1/2014

Seed VC

$99M

0

FY undefined

10

Date

4/25/2019

6/13/2017

7/14/2015

3/1/2014

Round

Dead

Unattributed

Series B

Seed VC

Amount

$99M

$99M

Investors

Dead

Valuation

$99M

$99M

$107.22M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Arivale Deal Terms

1 Deal Term

Arivale's deal structure is available for 1 funding round, including their Series B from July 14, 2015.

Round

Series B

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Arivale Investors

4 Investors

Arivale has 4 investors. Spectrum Health Ventures invested in Arivale's Unattributed funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/13/2017

6/13/2017

1
Unattributed

Corporate Venture

Michigan

00/00/0000

00/00/0000

Maveron

Subscribe to see more

Venture Capital

Washington

00/00/0000

00/00/0000

ARCH Venture Partners

Subscribe to see more

Venture Capital

Illinois

00/00/0000

00/00/0000

Polaris Partners

Subscribe to see more

Venture Capital

Massachusetts

First funding

6/13/2017

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/13/2017

00/00/0000

00/00/0000

00/00/0000

Investor

Maveron

ARCH Venture Partners

Polaris Partners

Rounds

1
Unattributed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Venture Capital

Venture Capital

Location

Michigan

Washington

Illinois

Massachusetts

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Arivale to Competitors

OmeCare Logo
OmeCare

OmeCare provides physicians and their patients with genetic information to improve or maintain health and wellness. The company's mobile health applications merge artificial intelligence and deep learning with personal genetic information that provides personalized health and wellness guidance.

metaMe Health Logo
metaMe Health

metaMe Health develops digital therapeutics for the treatment of gastrointestinal (GI) conditions. Its platform links people suffering from irritable bowel syndrome (IBS) to therapists and offers live video sessions, tracks patient progress, and manages scheduling and billing. The company was founded in 2016 and is based in Chicago, Illinois.

D
Digbi Health

Digbi Health provides microbiome genetic-based virtual care solutions to people living with digestive and metabolic illnesses. It offers services such as personalized food recommendations, weight management, digital health coaching, exercise regimen, food tolerance report, vitamin and aging metabolism, and more. It was founded in 2018 and is based in Mountain View, California.

Helix Logo
Helix

Helix works as a population genomics company operating in the healthcare and life sciences sectors. The company provides solutions that enable health systems, public health organizations, and life science companies to integrate genomic data into patient care and public health decision-making. Its primary customers are health systems, public health entities, and life science companies. It was founded in 2015 and is based in San Mateo, California.

Color Logo
Color

Color operates as a healthcare technology company democratizing access to genetic information. It offers color tests for patients to detect hereditary cancers such as breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers. It was formerly known as Color Global. It was founded in 2014 and is based in Burlingame, California.

Advisor360 Logo
Advisor360

Advisor360 is a wealth technology company providing a financial advisory platform capable of CRM, performance reporting, financial planning, trading, model management and rebalancing, operations and workflow, analytics, and document imaging.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.